Content of Medication Analysis in our journal

        Published in last 1 year |  In last 2 years |  In last 3 years |  All
    Please wait a minute...
    For Selected: Toggle Thumbnails
    Research Progress of Sodium-glucose Cotransporter 2 Inhibitor in the Treatment of T2DM Complicated with Coronary Heart Disease
    Zikang FU, Haiying LI, Ping LI
    Chinese General Practice    2022, 25 (12): 1493-1499.   DOI: 10.12114/j.issn.1007-9572.2022.02.024
    Abstract865)   HTML27)    PDF(pc) (1721KB)(770)       Save

    Diabetes is an independent risk factor for coronary heart disease, and the two are mutually causal in disease progression. Sodium-glucose cotransporter 2 inhibitor is a new oral medicine for the treatment of type 2 diabetes mellitus, which can play a hypoglycemic effect by blocking the reabsorption of glucose by the renal proximal convoluted tubules and increasing the excretion of urine glucose. A large number of studies have confirmed that in addition to hypoglycemic effects, SGLT2 inhibitors can also benefit in the treatment of coronary heart disease. This article mainly reviews the research progress and mechanism of SGLT2 inhibitors in the treatment of T2DM complicated with coronary heart disease.

    Reference | Related Articles | Metrics
    Progress on Drug Therapy for Opioid-induced Constipation
    Jiachun NI, Zengjin CAI, Qiong JIANG, Haibo LAN, Xiangdong YANG, Wenbin FAN
    Chinese General Practice    2022, 25 (12): 1499-1505.   DOI: 10.12114/j.issn.1007-9572.2021.02.092
    Abstract889)   HTML18)    PDF(pc) (1696KB)(393)       Save

    Opioid-induced constipation (OIC) is one of the common adverse reactions of opioids, which may affect the quality of life and follow-up treatment compliance of patients. With the rise of number of cancer patients worldwide and the increase in the use of opioids in chronic non-cancerous pain, the number of OIC patients will increase accordingly. Therefore, how to achieve effective analgesia and balance the occurrence of analgesia and OIC is one of the clinical problems that need to be resolved urgently. At present, the main therapeutic drugs for OIC mainly include oral laxatives and peripheral μ-opioid receptor antagonists, secretagogues, traditional Chinese medicines, etc. This paper mainly analyzed the drug therapy of OIC, in order to provide a reference for the effective clinical prevention and treatment of OIC.

    Table and Figures | Reference | Related Articles | Metrics